Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blinding01:11

Blinding

3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
Randomized Experiments01:13

Randomized Experiments

8.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.8K
Blind Procedures02:07

Blind Procedures

12.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.8K
Prediction Intervals01:03

Prediction Intervals

3.1K
The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
3.1K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

226
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
226
Binomial Probability Distribution01:15

Binomial Probability Distribution

15.1K
A binomial distribution is a probability distribution for a procedure with a fixed number of trials, where each trial can have only two outcomes.
The outcomes of a binomial experiment fit a binomial probability distribution. A statistical experiment can be classified as a binomial experiment if the following conditions are met:
There are a fixed number of trials. Think of trials as repetitions of an experiment. The letter n denotes the number of trials.
There are only two possible outcomes,...
15.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating Preclinical Insights for Adaptive Dose Escalation in Phase I Oncology Trials.

Pharmaceutical statistics·2026
Same author

Dual-Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time-to-Event Group Sequential Trials.

Statistics in medicine·2026
Same author

NALIRIFOX in Japanese treatment-naïve patients with metastatic pancreatic adenocarcinoma: an open-label, phase II trial design.

Future oncology (London, England)·2025
Same author

Futility Interim Analysis Based on Probability of Success Using a Surrogate Endpoint.

Pharmaceutical statistics·2024
Same author

A comparison of model-free phase I dose escalation designs for dual-agent combination therapies.

Statistical methods in medical research·2024
Same author

A proper statistical inference framework to compare clinical trial and real-world progression-free survival data.

Statistics in medicine·2022

Related Experiment Video

Updated: Jan 10, 2026

Measuring Attention and Visual Processing Speed by Model-based Analysis of Temporal-order Judgments
13:00

Measuring Attention and Visual Processing Speed by Model-based Analysis of Temporal-order Judgments

Published on: January 23, 2017

10.3K

Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials.

Jingyan Fu1, Dan Zhao2, Donia Skanji3

  • 1Department of Statistics, Rice University, Houston, Texas, USA.

Statistics in Medicine
|November 25, 2025
PubMed
Summary
This summary is machine-generated.

Predicting clinical trial event times is vital for efficient drug development. A new Bayesian method (BayesPET) accurately forecasts event timings, even with treatment effects, improving trial execution and accelerating therapy delivery.

Keywords:
Bayesian modelevent predictionlabel‐switchingmixture‐Weibull modeltime‐to‐event endpoints

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.0K
A Tactile Automated Passive-Finger Stimulator TAPS
19:44

A Tactile Automated Passive-Finger Stimulator TAPS

Published on: June 3, 2009

14.2K

Related Experiment Videos

Last Updated: Jan 10, 2026

Measuring Attention and Visual Processing Speed by Model-based Analysis of Temporal-order Judgments
13:00

Measuring Attention and Visual Processing Speed by Model-based Analysis of Temporal-order Judgments

Published on: January 23, 2017

10.3K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.0K
A Tactile Automated Passive-Finger Stimulator TAPS
19:44

A Tactile Automated Passive-Finger Stimulator TAPS

Published on: June 3, 2009

14.2K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Pharmacoeconomics

Background:

  • Accurate prediction of milestone dates in event-driven clinical trials is critical for decision-making and resource allocation.
  • Current methods for predicting event times in blinded randomized clinical trials (RCTs) often assume no treatment effect, leading to biased predictions when a treatment effect exists.

Purpose of the Study:

  • To introduce a novel Bayesian Prediction of Event Times (BayesPET) method for predicting event timings in blinded RCTs.
  • To address the limitation of existing methods by allowing for different time-to-event distributions between treatment and control arms.

Main Methods:

  • Developed the BayesPET method using a mixture Weibull model for interim event times.
  • Addressed the label-switching challenge in mixture models using truncated priors.
  • Validated the method through extensive simulations and real-world phase 3 clinical trial data.

Main Results:

  • The BayesPET method demonstrated superior predictive performance compared to existing methods.
  • The model showed effectiveness in both blinded and unblinded trial settings.
  • Accurate predictions were achieved even when treatment arms had different time-to-event distributions.

Conclusions:

  • The BayesPET method offers a more accurate approach to predicting event times in clinical trials, especially when treatment effects are present.
  • This improved prediction supports more effective trial execution and can accelerate the development of new therapies.
  • The method enhances strategic planning and resource optimization in clinical trial management.